1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2        South & Central America Overactive Bladder Treatment Market– By Disease Type

1.3.3        South & Central America Overactive Bladder Treatment Market – By Country

2.           South & Central America Overactive Bladder Treatment Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America Overactive Bladder Treatment Market – Market Landscape

4.1         Overview

4.2         South & Central America PEST Analysis

4.3         Expert Opinion

5.           South & Central America Overactive Bladder Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increase in Prevalence of Urinary Incontinence

5.1.2        Growing Incidence of Urinary Tract Infections

5.2         Key Market Restraints

5.2.1        Recalls of Therapeutic Drugs

5.3         Key Market Opportunities

5.3.1        Increasing Number of Mergers and Acquisitions

5.4         Future Trends

5.4.1        Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5         Impact analysis

6.           South & Central America Overactive Bladder Treatment Market – South & Central America Analysis

6.1         South & Central America Overactive Bladder Treatment Market Revenue Forecast and Analysis

7.           South & Central America Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1         Overview

7.2         South & Central America Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3         Mirabegron

7.3.1        Overview

7.3.2        Mirabegron: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4         Botox

7.4.1        Overview

7.4.2        Botox: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5         Neurostimulation

7.5.1        Overview

7.5.2        Neurostimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3        Transcutaneous Sacral Nerve Stimulation

7.5.3.1          Overview

7.5.3.2          Transcutaneous Sacral Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4        Transcutaneous Tibial Nerve Stimulation

7.5.4.1          Overview

7.5.4.2          Transcutaneous Tibial Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5        Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1          Overview

7.5.5.2          Percutaneous Posterior Tibial Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6        Others

7.5.6.1          Overview

7.5.6.2          Others: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6         Anticholinergics

7.6.1        Overview

7.6.2        Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3        Solifenacin

7.6.3.1          Overview

7.6.3.2          Solifenacin: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4        Oxybutynin

7.6.4.1          Overview

7.6.4.2          Oxybutynin: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5        Fesoterodine

7.6.5.1          Overview

7.6.5.2          Fesoterodine: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6        Darifenacin

7.6.6.1          Overview

7.6.6.2          Darifenacin: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7        Tolterodine

7.6.7.1          Overview

7.6.7.2          Tolterodine: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8        Trospium

7.6.8.1          Overview

7.6.8.2          Trospium: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9        Other Anticholinergics

7.6.9.1          Overview

7.6.9.2          Other Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7         Intravesical Instillation

7.7.1        Overview

7.7.2        Intravesical Instillation: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.           South & Central America Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1         Overview

8.2         South & Central America Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3         Idiopathic Overactive Bladder

8.3.1        Overview

8.3.2        Idiopathic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Neurogenic Overactive Bladder

8.4.1        Overview

8.4.2        Neurogenic: South & Central America Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9.           Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

Overview

9.1.2        South & Central America: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.2.1          Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2          Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3          Brazil: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.1.2.3.1.1       Brazil: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.2.3.1.2       Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.2.4          Brazil: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.1.3        Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1          Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1          Argentina: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.1.3.1.1.1       Argentina: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.3.1.1.2       Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2          Argentina: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

9.1.3.2          Rest of South & Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1          Rest of South & Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2          Rest of South & Central America: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (USD Million)

9.1.3.2.2.1       Rest of South & Central America: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.3.2.2.2       Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.3          Rest of South & Central America: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (USD Million)

10.        Overactive Bladder Treatment Market– Industry Landscape

10.1      Overview

10.2      Organic Developments

10.2.1     Overview

11.        Company Profiles

11.1      Astellas Pharma Inc

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      AbbVie Inc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Teva Pharmaceutical Industries Ltd

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Endo Pharmaceuticals Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      HiSouth & Central Americaitsu Pharmaceutical Co., Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Medtronic Plc

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Pfizer Inc

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Argentina Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of South & Central America Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (USD Million)

Table 10.          Rest of South & Central America Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of South & Central America Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of South & Central America Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Glossary of Terms

LIST OF FIGURES

Figure 1.           South & Central America Overactive Bladder Treatment Market Segmentation

Figure 2.           South & Central America Overactive Bladder Treatment Market Segmentation, By Country

Figure 3.           South & Central America Overactive Bladder Treatment Market Overview

Figure 4.           Mirabegron Segment Held Largest Share by Pharmacotherapy in South & Central America Overactive Bladder Treatment market

Figure 5.           Argentina Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7.           South & Central America: PEST Analysis

Figure 8.           South & Central America Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 9.           South & Central America Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10.        South & Central America Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 11.        Mirabegron: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Botox: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Neurostimulation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Transcutaneous Sacral Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        Transcutaneous Tibial Nerve Stimulation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 16.        Percutaneous Posterior Tibial Nerve: South & Central America Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17.        Others: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 18.        Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Solifenacin: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Oxybutynin: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Fesoterodine: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Darifenacin: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Tolterodine: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        Trospium: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Other Anticholinergics: South & Central America Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Intravesical Instillation: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        South & Central America Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 28.        Idiopathic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Neurogenic: South & Central America Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        South & Central America: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 31.        Brazil: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Argentina: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Rest of South & Central America: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)